Cardiac safety of treosulfan chemotherapy prior to stem cell transplantation in patients with leukemia.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517377-24-00

Acronym

MC-FludT.18/QT

Enrollment

Registered

2024-10-18

Start date

2022-12-20

Completion date

2025-10-23

Last updated

2025-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with AML ( Acute myeloid leukaemia) or MDS (Myelodysplastic syndrome) undergoing allogeneic hematopoietic stem cell transplantation

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026